Is Rituximab Used for RPGN? An Evolving Role in Rapidly Progressive Glomerulonephritis
•
5 min read
Historically, the management of rapidly progressive glomerulonephritis (RPGN) relied on broad-spectrum immunosuppressants, like cyclophosphamide and corticosteroids. The emergence of targeted therapies, including the anti-CD20 monoclonal antibody **rituximab**, has introduced a new treatment paradigm for certain forms of the disease, prompting the question: **Is rituximab used for RPGN?**.
